The raw data for Fig 8A. by Hongjoo An (21703199)

Subjects:

Demographic information. by Silas Manning (22693338)

Subjects:

Age-Period-Cohort Model Analysis of Gastric Cancer Incidence and Mortality in Taiwan. by Xiaohuang Yang (10182727)

Subjects:

Trends of age-specific burden of gastric cancer in Taiwan by gender from 1990 to 2021. by Xiaohuang Yang (10182727)

Subjects:

Projections of Gastric Cancer Incidence and Mortality Burden in Taiwan Through 2036. by Xiaohuang Yang (10182727)

Subjects:

Comparison of the burden of gastric cancer by age in Taiwan between 1990 and 2021. by Xiaohuang Yang (10182727)

Subjects:

Age-specific numbers and rates of incidence, prevalence, deaths and DALYs for gastric cancer in Taiwan, 2021. by Xiaohuang Yang (10182727)

Subjects:

Joinpoint Analysis of ASIR, ASPR, ASMR, and ASDR of gastric cancer in Taiwan, 1990–2021. by Xiaohuang Yang (10182727)

Subjects:

Microscopic examination of fetal placenta exposed to <i>U.simensis</i> essential oil: D-decidua, DA-decidual artery, DV-decidual vein, blue arrow head-maternal blood space, CBV-cho... by Bickes Wube (21678222)

Subjects:

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Changes in growth characteristics (A = shoot length; B = root length; C = collar diameter; D = number of leaves) of M. stenopetala under drought conditions. by Nadia Khater (22553166)

Subjects:

The CDF of normal and tangential contact forces in numerical specimens after compression considering different particle morphologies: (a) normal contact force; (b) tangential conta... by Yongfeng Zhu (7361045)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

HEK.219 cells were treated with the indicated siRNAs for 24h. by Lorenza Cutrone (21144285)

Subjects:

HSF2 expression sustains KSHV infection in KLEC. by Lorenza Cutrone (21144285)

Subjects:

Primers used in ChIP-PCR. by Lorenza Cutrone (21144285)

Subjects:

Primers used in RTqPCR. by Lorenza Cutrone (21144285)

Subjects: